BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23977152)

  • 21. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.
    Yu Z; Feng J; Wang W; Deng Z; Zhang Y; Xiao L; Wang Z; Liu C; Liu Q; Chen S; Wu M
    Oncogene; 2020 Apr; 39(15):3163-3178. PubMed ID: 32051553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.
    Navarro A; Tejero R; Viñolas N; Cordeiro A; Marrades RM; Fuster D; Caritg O; Moises J; Muñoz C; Molins L; Ramirez J; Monzo M
    Oncotarget; 2015 Oct; 6(31):31544-56. PubMed ID: 25742785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance.
    Chen J; Ye L; Zhang L; Jiang WG
    Int J Oncol; 2009 Jul; 35(1):159-66. PubMed ID: 19513563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
    Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
    Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
    Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
    Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
    Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
    Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
    Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
    Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma.
    Zhao S; Guo X; Mizutani KI; Yamaguchi R; Yamada S; Gu C; Uramoto H
    Int J Med Sci; 2021; 18(9):1980-1989. PubMed ID: 33850468
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers.
    Jang JS; Jeon HS; Sun Z; Aubry MC; Tang H; Park CH; Rakhshan F; Schultz DA; Kolbert CP; Lupu R; Park JY; Harris CC; Yang P; Jen J
    Clin Cancer Res; 2012 Jul; 18(13):3658-67. PubMed ID: 22573352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
    Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
    J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.